etoposide has been researched along with Nail Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castelo-Soccio, L; Rubin, AI; Stephens, M | 1 |
| Bhattacharya, S; Maiti, A | 1 |
| von Bergwelt-Baildon, MS; Weihrauch, MR | 1 |
| Ben-Dayan, D; Djaldetti, M; Floru, S; Mittelman, M | 1 |
| Helmer, H; Kurz, C; Obermair, A; Pehamberger, K; Sevelda, P; Vavra, N | 1 |
| Cunningham, D; Forrest, GJ; Gilchrist, NL; Soukop, M | 1 |
2 review(s) available for etoposide and Nail Diseases
| Article | Year |
|---|---|
Transverse melanonychia in a child receiving chemotherapy.
Topics: Antineoplastic Agents; Dexamethasone; Etoposide; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Nail Diseases; Pigmentation Disorders | 2019 |
Transverse nail ridgings (Beau's lines) induced by chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Head and Neck Neoplasms; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Nail Diseases; Nails; Prednisone; Vincristine | 1994 |
4 other study(ies) available for etoposide and Nail Diseases
| Article | Year |
|---|---|
A patient with cancer and nail pigmentation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Cyclophosphamide; Doxorubicin; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma, B-Cell; Nail Diseases; Nails; Pigmentation Disorders; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2016 |
Nail dystrophy due to dose-intensive chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Nail Diseases; Prednisone; Procarbazine; Vincristine | 2009 |
Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fingers; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Nail Diseases; Ovarian Neoplasms; Toes | 1995 |
Onycholysis associated with cytotoxic drugs.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Nail Diseases; Prednisolone; Vincristine | 1985 |